Potential risk of monoclonal antibody of infliximab for inflammatory bowel disease

Clinical Medication Journal ›› 2013, Vol. 11 ›› Issue (3) : 39-42.

PDF(879 KB)
Welcome to visit Clinical Medication Journal!
PDF(879 KB)
Clinical Medication Journal ›› 2013, Vol. 11 ›› Issue (3) : 39-42.

Potential risk of monoclonal antibody of infliximab for inflammatory bowel disease

    {{javascript:window.custom_author_en_index=0;}}
  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2013, 11(3): 39-42

References

List( Publishing order | Descend order by publishing year | Descend order by cited within ) Chart analysis

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(879 KB)

Accesses

Citation

Detail
Sections
Recommended
Copyright © Clinical Medication Journal, All Rights Reserved.
Tel: 010-64178704转301/302/305/306　
E-mail：zazhi@vip.sina.com
Powered by Beijing Magtech Co. Ltd.

/

〈 〉